Age at onset (y) (mean, SD) | 53.48 (13.0) | 46.65 (11.5) | t=4.08 p=00006 |
Female n (%) | 80 (65.0) | 72 (72.7) | ns |
Current Smokers n (%) | 23 (18.7) | 40 (40.4) | χ2 12.7 (p<0,01) |
| | | OR 2.95 (1.6, 5.4) |
Alcohol consumers n (%) | 35 (28.5) | 28 (28.3) | ns |
Comorbidity n (%) | 92 (74.8) | 61 (61.6) | χ2 4.45 (p<0.05) |
| | | OR 1.21 (1.0, 1.5) |
CV risk factors n (%) | 92 (74.8) | 81 (81.8) | ns |
Polyarticular onset of AR n (%) | 61 (49.6) | 61 (61.6) | ns |
Extraarticular involvement n (%) | 17 (13.8) | 21 (21.2) | ns |
Possitive RF n (%) | 89 (72.4) | 79 (79.8) | ns |
Possitive ACPA n (%) | 70 (60.3) | 64 (68.1) | ns |
Duration of RA (m) (mean (SD) | 96.1 (63.1) | 96,0 (73.9) | ns |
MTX toxicity n (%) | 47 (38.2) | 59 (59.6) | χ2 10.0 (p<0.01) |
| | | OR 2.38 (1.4, 4.1)) |
MTX dose (mg) (mean, SD) | 15.6 (0.32) | 17.8 (0.37) | t=-4.52 p=00001 |